Fig. 4

Progression-free survival for patients with PIK3CA mutations with high and low risk of hyperglycemia (model 7) treated with alpelisib in SOLAR-1
Progression-free survival for patients with PIK3CA mutations with high and low risk of hyperglycemia (model 7) treated with alpelisib in SOLAR-1